The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
Open accessAbstract
BACKGROUND: To develop content validity of a comprehensive patient-reported outcome (PRO) measure following current best scientific methodology to standardize assessment of influenza (flu) symptoms in clinical research. METHODS: Stage I (Concept Elicitation): 1:1 telephone interviews with influenza-positive adults (≥18 years) in the US and Mexico within 7 days of diagnosis. Participants described symptom type, character, severity, and duration. Content analysis identified themes and developed the draft Flu-PRO instrument. Stage II (Cognitive Interviewing): The Flu-PRO was administered to a unique set of influenza-positive adults within 14 days of diagnosis; telephone interviews addressed completeness, respondent interpretation of items and ease of use. RESULTS: Samples: Stage I: N = 46 adults (16 US, 30 Mexico); mean (SD) age: 38 (19), 39 (14) years; % female: 56%, 73%; race: 69% White, 97% Mestizo. Stage II: N = 34 adults (12 US, 22 Mexico); age: 37 (14), 39 (11) years; % female: 50%, 50%; race: 58% White, 100% Mestizo. SYMPTOMS: Symptoms identified by >50%: coughing, weak or tired, throat symptoms, congestion, headache, weakness, sweating, chills, general discomfort, runny nose, chest (trouble breathing), difficulty sleeping, and body aches or pains. No new content was uncovered during Stage II; participants easily understood the instrument. CONCLUSIONS: Results show the 37-item Flu-PRO is a content valid measure of influenza symptoms in adults with a confirmed diagnosis of influenza. Research is underway to evaluate the suitability of the instrument for children and adolescents. This work can form the basis for future quantitative tests of reliability, validity, and responsiveness to evaluate the measurement properties of Flu-PRO for use in clinical trials and epidemiology studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., & Erikson, P. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.04054.x · Cited by 5,521
Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K., Martin, M. L., Molsen, E., & Ring, L. (2011) · Value in Health · doi:10.1016/j.jval.2011.06.013 · Cited by 1,135
Self-citationPatrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K., Martin, M. L., Molsen, E., & Ring, L. (2011) · Value in Health · doi:10.1016/j.jval.2011.06.014 · Cited by 1,095
Self-citationCoons, S. J., Gwaltney, C. J., Hays, R. D., Lundy, J. J., Sloan, J. A., Revicki, D. A., Lenderking, W. R., Cella, D., & Basch, E. (2009) · Value in Health · doi:10.1111/j.1524-4733.2008.00470.x · Cited by 537
Leidy, N. K., & Vernon, M. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826050-00002 · Cited by 204
Self-citationBeyond Intuition: Patient Fever Symptom Experience
Ames, N. J., Peng, C. Y.-C., Powers, J. H., Leidy, N. K., Miller‐Davis, C., Rosenberg, A., VanRaden, M. J., & Wallen, G. R. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.02.012 · Cited by 22
Self-citationMeasurement of rapid changes in health outcomes in people with influenza symptoms.
Osborne, R. H., Hawthorne, G., Papanicolaou, M., & Wegmueller, Y. (2000) · Figshare · Cited by 19
Research works printed but not linked: 2
- Food and Drug Administration. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regis. 2009;74:65132–3.
- Osborne RH, Norquist JM, Elsworth GR, Busija L, Mehta V, Herring T, et al. Development and validation of the Influenza Intensity and Impact Questionnaire (FluiiQ). Value Health. 2011;14:687–99. · doi:10.1016/j.jval.2010.12.005
Cited by
Estimation of Direct Healthcare Costs of Fungal Diseases in the United States
Benedict, K., Jackson, B. R., Chiller, T., & Beer, K. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy776 · Cited by 438
Memoli, M. J., Shaw, P. A., Han, A., Czajkowski, L., Reed, S., Athota, R., Bristol, T., Fargis, S., Risos, K., Powers, J. H., et al. (2016) · mBio · doi:10.1128/mbio.00417-16 · Cited by 374
Self-citationKimera, Z. I., Mshana, S. E., Rweyemamu, M. M., Mboera, L. E. G., & Matee, M. I. N. (2020) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-020-0697-x · Cited by 256
Powers, J. H., Patrick, D. L., Walton, M. K., Marquis, P., Cano, S., Hobart, J., Isaac, M., Vamvakas, S., Slagle, A., Molsen, E., et al. (2017) · Value in Health · doi:10.1016/j.jval.2016.11.005 · Cited by 191
Self-citationA systematic review: the current status of carbapenem resistance in East Africa
Ssekatawa, K., Byarugaba, D. K., Wampande, E., & Ejobi, F. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3738-2 · Cited by 93
Metadata
- Authors
- Powers, J. H., Guerrero, M. L., Leidy, N. K., Fairchok, M. P., Rosenberg, A., Hernández, A., Stringer, S., Schofield, C., Rodríguez-Zulueta, P., Kim, K., Danaher, P. J., Ortega-Gallegos, H., Bacci, E. D., Stepp, N., Galindo-Fraga, A., Clair, K. S., Rajnik, M., McDonough, E. A., Ridoré, M., Arnold, J. C., Millar, E. V., & Ruiz-Palacios, G. M.
- Venue
- BMC Infectious Diseases
- Published
- 2015-12
- Volume
- 16
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1471-2334 (ISSN-L)
- OpenAlex
- W2223575612
- Cited by
- 501
- References
- 7
- FWCI
- 20.41
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 35 d)
- Funders
- National Cancer Institute (HHSN261200800001E)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza. https://app.cochat.ai/papers/10.1186/s12879-015-1330-0
- The paper
- Powers, J. H., Guerrero, M. L., Leidy, N. K., Fairchok, M. P., Rosenberg, A., Hernández, A., Stringer, S., Schofield, C., Rodríguez-Zulueta, P., Kim, K., Danaher, P. J., Ortega-Gallegos, H., Bacci, E. D., Stepp, N., Galindo-Fraga, A., Clair, K. S., Rajnik, M., McDonough, E. A., Ridoré, M., . . . Ruiz-Palacios, G. M. (2015). Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza. BMC Infectious Diseases. https://doi.org/10.1186/s12879-015-1330-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.